The acute nature of the peritonitis and colitis models we utilized, with rapid kinetics for neutrophil and monocyte/macrophage activation, limits the testing window for our anti-DCIR mAbs once the disease has developed. The gene discussed is CLEC4A; the disease is peritonitis.